PRODUCTS NOT CURRENTLY AVAILABLE FOR COMMERCIAL SALE
HeLP™ Prostate Cancer Tests
When you’re faced with the possibility of prostate cancer, two questions matter most:
Do I actually have cancer?
If I do, is it the aggressive kind that needs urgent treatment?
HeLP™ tests from Hessian Labs are designed to give you and your doctor clear, reliable answers — using only a simple blood draw.
HeLP™ Detect PC
Helps show whether cancer is likely to be found on biopsy.
Can spare many men an unnecessary biopsy if their cancer risk is low.
Looks for specific protein signals linked only to prostate cancer — unlike the PSA test, which can rise for many reasons.
HeLP™ Monitor PC
Focuses on identifying aggressive prostate cancer.
Helps your doctor see if your cancer needs urgent treatment or can be safely watched.
Gives you more confidence in making the right decision for your version of the disease.
Why it matters:
Together, the HeLP™ tests reduce uncertainty, minimize unnecessary procedures, and guide the care that’s right for you — so you can move forward with clarity and confidence.
HeLP™ Breast Cancer Tests
When it comes to breast cancer, women and their doctors face three critical questions:
Is the lump or lesion invasive, or not?
If I carry a high-risk gene, is my condition progressing toward cancer?
Is my treatment working for me?
The HeLP™ Breast Cancer tests are designed to give clear answers — from a simple blood draw.
HeLP™ Define BC
Helps distinguish whether a breast lesion (like DCIS seen on a mammogram) is non-invasive or invasive cancer.
Provides clarity so doctors and patients can decide whether urgent treatment is needed.
HeLP™ Detect Progression BC (HeLP™ DP BC)
For women with genetic risks (BRCA1, BRCA2, Cowden’s, or Lynch syndrome).
Detects early signs that the condition may be progressing toward cancer, allowing earlier and more proactive care.
HeLP™ Monitor Therapy BC
Shows whether targeted therapies are working — or not.
Helps patients and doctors adjust treatment sooner, with confidence.
Looking ahead: The HeLP™ platform is also being developed for other diseases, including pancreatic cancer and Alzheimer’s, expanding its potential to help patients across multiple conditions.